Roivant Sciences Ltd. (ROIV) - Dilution Analysis

10-K filing | 693.9M shares outstanding

10-Q filing | 680.9M shares outstanding

10-Q filing | 680.3M shares outstanding

10-K filing | 725.4M shares outstanding

10-Q filing | 722.7M shares outstanding

10-Q filing | 735.5M shares outstanding

10-Q filing | 735.8M shares outstanding

10-K filing | 783.2M shares outstanding

8-K filing: Roivant Sciences Ltd. authorized a common share repurchase program of up to $1.5 billion and entered into a share repurchase agreement with Sumitomo to repurchase 71,251,083 common shares at $9.10 per share, for an aggregate purchase price of approximately $648.4 million. ($648.4M proceeds)

10-Q filing | 800.6M shares outstanding

10-Q filing | 770.2M shares outstanding

S-3 filing: The filing is an S-3 shelf registration for up to $1.5 billion in common shares, preference shares, debt securities, warrants, or units.

10-Q filing | 759.3M shares outstanding

10-K filing | 712.8M shares outstanding

10-Q filing | 713.3M shares outstanding

10-Q filing | 699.9M shares outstanding

8-K filing: Roivant Sciences Ltd. closed an underwritten offering of 30,000,000 common shares at $5.00 per share on November 10, 2022, with 20,000,000 shares sold by the company and 10,000,000 shares sold by selling shareholders, resulting in total gross proceeds of $150 million. ($150.0M proceeds)

POS AM filing: The filing registers the issuance of common shares upon the exercise of public and private warrants.

POS AM filing: This is a POS AM filing to terminate the offering of securities pursuant to the Registration Statement. The Registrant removes from registration any and all securities registered under the Registration Statement that remain unsold on the date hereof and terminates the effectiveness of the Registration Statement.

POS AM filing: This is a post-effective amendment to deregister securities from a previous S-1 filing (File No. 333-261853) in connection with a new S-3 registration statement (File No. 333-267503). The amendment removes from registration any and all securities registered under the Registration Statement that remain unsold as of immediately prior to the effectiveness of the Form S-3 Registration Statement and terminates the effectiveness of the Registration Statement.

S-3 filing: This is an S-3 filing for a shelf offering of up to 566,982,174 common shares by selling securityholders and an at-the-market offering up to $400 million. The company intends to use the net proceeds from the sale of any securities offered under this prospectus for working capital and general corporate purposes.

10-Q filing | 695.9M shares outstanding

POS AM filing: This POS AM filing relates to the offering of Common Shares underlying Warrants with an exercise price of $11.50 per share.

10-K filing | 700.8M shares outstanding

S-1 filing: This is an S-1 filing for common stock. The price or prices at which Common Shares may be sold by the Holder under this prospectus cannot currently be determined.

10-Q filing | 692.1M shares outstanding

S-1 filing: This is an S-1 filing for common stock. The price per share is undetermined.

10-Q filing | 684.8M shares outstanding

S-1 filing: This S-1 filing discusses the offering price of Common Shares underlying Warrants, set at an exercise price of $11.50 per share. It also mentions the company's listing on The Nasdaq Global Market under the symbols 'ROIV' and 'ROIVW'.

10-Q filing | 222.7M shares outstanding